Standard blood tests can now predict women likely to develop pre-eclampsia
A new blood test could help detect women at risk for preeclampsia during labor, a significant cause of maternal mortality, according to research presented at AN... Read more.
Cholera Vaccine Crisis: Global Cholera Vaccine Stockpile Depleted- WHO
The WHO reports a total depletion of the global cholera vaccine stockpile, posing severe challenges to outbreak response efforts and disease control.... Read more.
Rwanda: Over 700 Vaccinated Against Marburg Virus Disease
Introduction Rwanda is making headlines with its proactive measures to combat the deadly Marburg virus, a close relative of the... Read more.
Rwanda Faces Marburg Virus Outbreak: Travel Advisory Sparks Criticism and Global Health Concerns
Rwanda is facing its first Marburg virus outbreak, prompting U.S. travel advisories that raise public health concerns and spark international criticism.... Read more.
Their bodies, their words: meet the winners of Nigeria’s HPV essay contest
Girls in Nigeria’s Edo state were invited to take part in an essay-writing competition looking into the HPV vaccine. This... Read more.
Find Out The Never Before ‘Fully Recognized’ Benefit of Vaccine, according to WHO
A new WHO Technical Report has detailed never before fully recognised benefits of vaccines. This post is based on the technical report.... Read more.
World Sight Day: Why Children Should Spend More Time Outdoors
World Sight Day on October 10 highlights the urgent need for awareness around children's eye health as myopia rates soar, signaling a global "myopia epidemic."... Read more.
Alarming Impact of Screen Time on Children’s Mental Health
In our screen-dominated world, understanding the impact of screen time on children's mental health is crucial. Recent research uncovers alarming links between s... Read more.
Mpox Outbreak: Vaccination Rollout Begins in Bayelsa and Rivers States
The NPHCDA has launched the Mpox vaccination initiative, starting in Bayelsa and Rivers, to combat rising cases and protect vulnerable populations.... Read more.
Cervical Cancer Breakthrough: WHO Approves New Single-Dose HPV Vaccine
The WHO has approved Cecolin®, a fourth HPV vaccine, for single-dose use, aiming to boost cervical cancer prevention and enhance vaccination efforts globally.... Read more.